Week 271 Review - Jubilee Metals soars in an otherwise crappy week

Lots of big losses this week, with deficit between cost and value widening by £5,510 to £25,868 and portfolio value dropping back below £100k to £96,625. I did however bank some profit and take advantage of that to write off some losses.

Biggest loser was DDDD:4D Pharma which fell 14% and is now only 93% up compared to over 200% a few weeks ago. I'm counting on it bouncing back as I've added it to my trading account, but so far that's been a disaster.

OPTI:Optibiotix was the next worst performer, dropping 8% and being responsible for much of the week's losses. I'm pretty certain this is the most frustrating share to be a long term holder.

I'm happy to say thet the next worst performer was SBTX:SkinBioTherapeutics which dropped 7%. The main reason I'm happy is I'm back invested, but clearly sad that along with commission and spread, the price has dropped to below what I paid, so crappy timing once more.

BLU:Blue Star Capital has been pretty static for a long time, with a small surge when they started investing in eSports companies. This week investors got bored and the price dropped 5% to go 82% down on my original purchase price.

FXPO:Ferrexpo has been up and down like a yo-yo and this week dropped 5% for no particular reason.

There were only 2 shares with rises of more than 5% this week. The first was TLOU:Tlou Energy which has been climbing every day. My main holding went up 7% but is still 58% down, and I sold my trading holding for a 20% profit. Not bad for a few weeks holding.

Share of the Week by miles is JLP:Jubilee Metals which soared 18% higher and is now 43% in profit. The only profitable share in my ISA and now a long term hope for an eventual dividend. People are suggesting 40p a share is a reasonable target, so a 5% dividend at that share price would be worth £2,800 a year, or alternatively I could sell up for a £50k profit, which might be more tempting.

It doesn't looks as bad as I thought on this chart

The trend line is still slightly downwards, but at least this week we're not bouncing straight off it. Hopefully that's not next week's destiny.

The ISA and share portfolios look like this

			Weekly Change
Cash	£33.23		+£0
Portfolio cost	£62,122.68		-£243.81
Portfolio sell value (bid price-commission)	£47,936.48	(-22.8%)	-£2,125.40
Potential profits	£2,647.28		+£1,137.19
Yr 6 Dividends	£0		+£0
Yr 6 Profit from sales	-£243.81		-£243.81
Yr 6 Average monthly cash profit	-£100.48	(-1.9%)	-£95.00
Total Dividends	£1,343.15		+£0
Total Profit from sales	£20,182.80		-£243.81
Average monthly cash profit	£340.30	(6.6%)	-£5.17
(Sold stocks profit + Dividends - Fees  / Months)
Performance/Injection	9.8%		-0.1%
Compound performance	51%		-1%

First of all I decided to write off a couple of shares that I bought when I first started and which have either de-listed or gone bust. Technically I still own the shares, but nothing will ever happen to them, and if by some miracle it does I'll worry about how to account for it then. 

TRK:Torotrak was one of the first shares I bought, when I had the crazy notion that finding a share that was at its cheapest ever price was a great plan, despite the reason for it being so cheap was that it was about to go bust. I was naive enough to believe that companies didn't go bust, but I was wrong. Fortunately I only bought 1,500 shares at 6.2272p costing £106.38 so my stupidity didn't cost me much as I lost it all.

The next write-off was an almost identical story. I bought BLUR:Blur Group shares early on, and they became MAIS:Maistro. I had 148,023 shares bought at 0.084391p costing £137.43. These haven't gone bust yet, but have de-listed the shares so getting rid of them would be difficult, but there's no point as the commission would be more than they are worth. Maybe one day they'll surprise me, but I doubt it.

The write-off didn't have much effect on long term performance, dropping average monthly profit by just over £5, but the year 6 average is looking a bit desperate until I sell something for a profit.

Meanwhile the portfolio value was hammered by the various drops this week, but potential profit rose by £1,137 as JLP:Jubilee Metals took off rather beautifully following a production update.

Just a little blip (I hope).

I'd say that trend line is completely flat now. 12 months of zero progress, but at least it's not pointing downwards any more.

The SIPP looks like this after week 255

			Weekly Change
Cash	£30.14		-£102.73
Portfolio cost	£57,726.57		+£542.87
Portfolio sell value (bid price - commission)	£46,833.67	(-18.8%)	-£3,506.08
Potential profits	£786.01		-£1,650.25
Yr 5 Dividends	£162.58		+£0
Yr 5 Interest	£0.03		+£0
Yr 5 Profit from sales	£2,187.80		+£440.13
Yr 5 Average monthly cash profit	£201.87	(4.2%)	+£37.07
Total Dividends	£2,061.82		+£0
Total Interest	£0.20		+£0
Total Profit from sales	£14,736.90		+£440.13
Average monthly cash profit	£275.20	(5.7%)	+£6.42
(Sold stocks profit + Dividends - Fees / Months)
Performance/Injection	8.8%		+0.2%
Compound performance	43%		+1%

I sold my 45,772 JLP:Jubilee Metals shares for 6.2101p after buying them for 4.3499p a few weeks ago. That gave me £830.55 (41.2%) profit. At the same time I got so fed up of the dodgy goings on at MMX:Minds + Machines that I decided to bail out at a loss and still be in profit for the week. I sold my 13,184 shares at 4.8p after buying them at 7.58p and took a £390.42 (38.2%) loss. The end result was a net profit of £440 for the week, which took the monthly average for year 5 up to 4.2%, but the long term average only improved by 0.1% to 5.7%, although performance against injection amount improved by 0.2% to 8.8%.

The sales liberated £3,451 so with £100 in cash I had enough to buy a magic formula share as well as get back into SBTX:SkinBioTherapeutics.

I bought 68 shares in CMCL:Caledonia Mining at 1430p per share costing £997.95. This gets me a new magic formula share taking the total to 7, and gets me back into gold, and the quarterly dividend ex-date was on Thursday, although I think I'll only get £5 as it's a bit stingy.

So then I had to wait for the right moment to buy back into SBTX:SkinBioTherapeutics. There was much rejoicing when an RNS came out the next day announcing a placing at 16p. The share price dropped, and I hoped it would drop to 16p. However it held up, and I decided it was unlikely to get lower if a placing announcement wasn't enough to drop it. I bought 14,663 shares at 17.27p costing £2,556.20. I bought in two tranches as the Exchange Market Size for SBTX is only 7,500. It meant paying 2 lots of commission, but it means the trades are guaranteed to be processed online. I guess with hindsight I should have tried to do it in one go to compare the price as I may not have needed to do that. I'll try that next time! Needless to say they dropped further on Friday and I could have got them for 17p. Never mind eh!

Portfolio value was hammered as the biggest losers were in my SIPP, and potential profit dropped by a whopping £1,650 as I cashed in profits and nearly everything else dropped. There are only 3 shares in profit now, when there were 6 a few weeks ago.

This chart is worse than the ISA chart, going almost as low as the recent dips.

This chart is worse too, with a distinct down trend and a bigger deficit than the last 3 dips, but then over £2,000 profit has been taken this week.

The trading account looks like this after week 221

			Weekly Change
Cash	£227.79		+£7.07
Portfolio cost	£2,353.63		-£0.53
Portfolio sell value (bid price - commission)	£1,513.83	(-35.7%)	-£123.70
Potential profits	£0		-£41.32
Year 5 Dividends	£0		+£0
Year 5 Profit	£261.23		+£106.53
Yr 5 Average monthly cash profit	£87.08	(44.4%)	+£31.22
Dividends	£47.92		+£0
Profit from sales	£547.60		+£106.53
Average monthly cash profit	£11.68	(6.0%)	+£2.05
(Sold stocks profit + Dividends - Fees  / Months)

I sold my 21,739 shares in TLOU:Tlou Energy for 2.9p after paying 2.3p and made £106.53 (20.3%) profit. That significantly improved the projected year 5 profits, but those will settle down as they average out across the year. The more important long term performance improved by £2 a month to £11 and a nice 6% return. It's less than the 10% target, but a drastic improvement on the rather pitiful performance over the last few years.

I took out £100 so the injection amount dropped to £1,900, and I re-invested in DDDD:4D Pharma as I believed the recent drop was over-done, and that they should rebound very soon. I bought 473 shares at 105.595p costing £511.41, but as usual I got the timing wrong and I could have got them for 95p if I'd waited a few days. They are currently down by 14% but hopefully not for long.

The dip in portfolio value was only £17 more than the profits I took, so it wasn't a bad week for this account.

The drop in the green line reflects the drop in the injection amount, so that's fair enough.

A more severe drop here as DDDD:4D Pharma has slipped downwards, but above the trend line which is getting steeper in the right direction. I just need the other shares to wake up so I'm not just trading the one £500 pot all the time.

Here's my wish list:

1. SBTX:SkinBioTherapeutics to drop in price to 16p. Given this was 19.5p last week, I'm happy to have bought back at 17.2p. It's not the 16p I'd hoped for, but I think anything under 20p is good value. I will continue to trade these shares as I believe they will remain very volatile for at least the next 12 months. I just need to be more disciplined about keeping the cash instead of chucking it at other shares, as I really want to extend my holding. The 14,663 shares I have now compare to 14,249 when I last held them in my SIPP, so I have succeeded in increasing my holding as well as making £690 profit. However, if you go back to when I held these the time before, I had 16,983 and sold them for £842 profit. I should therefore be targeting holding more than 16,983. These have been good to me so far, with £2,029 profit from my SIPP and £1,136 profit from my ISA. I just need to be careful though, as one day they will absolutely rocket. I'll now close this wish.
   
2. TLOU:Tlou Energy announce de-watering has resumed. Still no news of this, but the price continues to sneak upwards so there is concerted buying from somewhere. I'm still £1,688 in the red so it's going to be a long slog back to break even.
3. JLP:Jubilee Metals to announce permission to process platinum rich tailings at DCM. This hasn't come through yet, but there are hints it is imminent. I'm going to add that the fine chrome plant move is completed and operational. At the moment the share price doesn't need the news as it's soaring anyway, but every little helps.
4. OPTI:Optibiotix to get within 10% of profit. Well this one is much needed as the accounts are 16%, 19% and 20% down at the moment. Why can't it hold above 60p? It's incredibly frustrating.
   
5. CAML:Central Asia Metals re-instate their dividend. Still waiting and hoping it will be in the next few weeks.